The new non-GMO ingredient, targeted for use in salmon and shrimp farming, is designed to replace fish oil and fishmeal, reducing pressure on marine ecosystems.
The legislation aims to modernise outdated FDA regulations that impede feed ingredients approval processes.
The company aims to integrate its advanced yeast cultivation technology with Leiber’s expertise in processing yeast extract and yeast cell walls.
The technical upgrade requires a partial shutdown of the two facilities for approximately 8-10 weeks between May and July 2025.
Biostrong, one of the products, enhances poultry’s digestive health to optimise growth.